Allergan, Inc. (AGN)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Brenton L. Saunders
Employees:
16,900
CLONSHAUGH BUSINESS AND TECHNOLOGY PARK, COOLOCK, DUBLIN, IRELAND D17 E400
(216) 523-5000

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded on in 1984 and is headquartered in Dublin, Ireland.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 2.609 Million
P/E Ratio21.7337 Dividend Yield1.678 EPS-7.62
Price to Revenue3.6373 Debt to Equity0.3369 EBITDA2.794 Billion
Price to Book Value1.0095 Operating Margin-21.3448 Enterprise Value75.071 Billion
Current Ratio1.006 EPS Growth0.645 Quick Ratio0.729
1 Yr BETA 1.2649 52-week High/Low 0.0 / Profit Margin-15.3999
Operating Cash Flow Growth0.0 Altman Z-Score1.2235 Free Cash Flow to Firm 4.395 Billion

Are you looking for this stock instead?

View SEC Filings from AGN instead.

View recent insider trading info

Allergan, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AGN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TERMEER HENRI A

  • Director
 No longer subject to file 2015-03-17 0

PYOTT DAVID E I CHAIRMAN OF THE BOARD AND CEO

  • Officer
  • Director
 No longer subject to file 2015-03-17 0

GALLAGHER MICHAEL R

  • Director
 No longer subject to file 2015-03-17 0

BARLOW JAMES F SR. VP, CORP. CONTROLLER (PAO)

  • Officer
 No longer subject to file 2015-03-17 0

INGRAM DOUGLAS S PRESIDENT

  • Officer
 No longer subject to file 2015-03-17 0

LAVIGNE LOUIS J JR

  • Director
 No longer subject to file 2015-03-17 0

RAY RUSSELL T

  • Director
 No longer subject to file 2015-03-17 0

JONES TREVOR M

  • Director
 No longer subject to file 2015-03-17 0

WHITCUP SCOTT M EXECUTIVE VP, R&D, CSO

  • Officer
 No longer subject to file 2015-03-17 0

DUNSIRE DEBORAH

  • Director
 No longer subject to file 2015-03-17 0

PINKSTON ARNOLD A EVP AND GENERAL COUNSEL

  • Officer
 No longer subject to file 2015-03-17 0

DIRADOORIAN RAYMOND H EVPGLOBAL TECHNICAL OPERATIONS

  • Officer
 No longer subject to file 2015-03-17 0

PROCTOR TIMOTHY D

  • Director
 No longer subject to file 2015-03-17 0

SHERMAN SCOTT D EXECUTIVE VICE PRESIDENT, HR

  • Officer
 No longer subject to file 2015-03-17 0

GANGOLLI JULIAN S CVP & PRES, NORTH AMERICA

  • Officer
 No longer subject to file 2015-03-17 0

MCDONNELL PETER J

  • Director
 No longer subject to file 2015-03-17 0

HINDMAN JAMES M. EVP, FINANCE & BUS. DEV., CFO

  • Officer
 No longer subject to file 2015-03-17 0

EDWARDS JEFFREY L EVP, FIN & BUS. DEV., CFO

  • Officer
 0 2014-02-21 0

HUDSON DAWN E

  • Director
 11,600 2014-02-19 0

ENDICOTT DAVID J. CVP AND PRESIDENT, AGN MED

  • Officer
 No longer subject to file 2013-07-09 0

BOYER HERBERT W PH D

  • Director
 No longer subject to file 2013-04-29 0

RYAN STEPHEN J

  • Director
 No longer subject to file 2013-03-21 0

INGRAM ROBERT ALEXANDER

  • Director
 0 2012-10-29 0

HERBERT GAVIN S

  • Director
 214,760 2011-05-02 0

BALL F MICHAEL PRESIDENT

  • Officer
 39,305 2011-03-22 0

SCHAEFFER LEONARD D

  • FORMER DIRECTOR/RETIRED 5/3/11
 No longer subject to file 2011-03-14 0

GESTEN SAMUEL J EVP, GEN. COUNSEL & ASST. SEC.

  • Officer
 2,285 2011-02-17 0

DYER-BRUGGEMAN DIANNE EVP, HUMAN RESOURCES

  • Officer
 10,178 2010-02-22 0

EVANS HANDEL

  • Director
 29,218 2007-04-30 0

WILSON ROY J EXECUTIVE VP, HR AND IT

  • Officer
 27,113 2006-08-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments